Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extranasal Staphylococcus aureus colonization and nasal mupirocin eradication study
NL-OMON37698Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- May 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mupirocin in staphylococcal carrier state (2 arms), sponsored by Erasmus MC. Primary endpoints: Natural carriage state of Staphylococcus aureus and Effect of nasal eradication on carriage at multiple body sites. Planned start May 2012; status: not yet recruiting.
02
Drugs
mupirocin
03
Conditions
staphylococcal carrier state
Beyond the preview
Go deeper on NL-OMON37698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37698.